Uppsala, Sweden

Bjorn Herrmann

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2013.


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,411 
Other
 patents

Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bjorn Herrmann: Innovator in Pathogen Detection

Introduction

Bjorn Herrmann is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of pathogen detection, particularly through his innovative methods that enhance the diagnosis of infections caused by pathogenic organisms.

Latest Patents

Herrmann holds a patent for a "Method for detection of pathogenic organisms." This method includes differentiation between species, making it especially suitable for detecting and diagnosing infections by pathogenic organisms that are difficult to identify using conventional methods. The technique relies on the analysis of specific variable regions of the RNase P RNA gene, specifically the P3 and/or P19 regions. This innovation represents a significant advancement in the field of medical diagnostics.

Career Highlights

Throughout his career, Bjorn Herrmann has focused on developing methods that improve the accuracy and efficiency of pathogen detection. His work has been instrumental in addressing challenges faced by healthcare professionals in diagnosing infections.

Collaborations

Herrmann has collaborated with notable colleagues, including Pelle Stolt and Leif Kirsebom. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Bjorn Herrmann's contributions to the field of pathogen detection exemplify the importance of innovation in medical diagnostics. His patented method offers a promising solution for the detection of hard-to-identify pathogenic organisms, showcasing his commitment to improving healthcare outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…